PTHS logo

PTHS
Pelthos Therapeutics Inc.

819
Mkt Cap
$77.18M
Volume
11,868.00
52W High
$54.29
52W Low
$9.00
PE Ratio
-1.11
PTHS Fundamentals
Price
$23.00
Prev Close
$23.00
Open
$23.46
50D MA
$22.79
Beta
0.99
Avg. Volume
3,936.07
EPS (Annual)
-$23.04
P/B
1.91
Rev/Employee
$182,554.35
$75.10
Loading...
Loading...
News
all
press releases
News Placeholder
Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates
Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +28.35% and +3.78%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
The launch triggered a $5 million milestone payment to Ligand, which also holds a 56% stake in Pelthos and is eligible for royalties and additional commercial milestones.
Stocktwits·9mo ago
<
...
1
>

Latest PTHS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.